Dolphin Vision

What does a Startup need more: a working product or a fast-growing Market?   Of course, I don't know the answer to this question. And no one knows 🤠   But in the end, practice is the only criterion of truth. Six months ago, Dolphin Vision showcased our Arothera device at IDS in Cologne. A German businessman who supported our exhibition decided to try it in his office. At the time, Arothera was positioned as an aroma solution—spreading a pleasant fragrance while quietly deactivating airborne viruses. Last week, he called me again and offered to resume cooperation and become our distributor in Germany. What happened? It turned out that the only Arothera device installed in his office then allowed everyone to stay healthy while all his family members were sick with coronavirus.   Meanwhile, this businessman discovered that his employees were all healthy, but their families were sick. That is, even when they come home and contact and help their sick relatives, they do not get sick. 🤒 It was his ‘’Penny dropped’’ moment. For us, it was another proof: Arothera doesn’t just refresh the air. It protects people. Against flu. Against coronavirus. Against airborne infections in general. The story revealed something we’ve long suspected: people who breathe Arothera air at work may build a level of resistance that protects them even when exposed at home. It works almost like a continuous “airborne nasal spray”. Further testing is underway, but the real-world effect is already clear. Well, now let's get back to the question of large markets that are crucial (or not) for startups.  Our point of entry into the market was through a device that spread pleasant smells. At some point, we realised that people are willing to have a good smell every day and protection from viruses several times a year.  This decision worked well for us, people started to install the Arothera device in Gym clubs, schools, offices and nursing homes. But today we see our potential market differently. In our time, when trust in vaccination is declining and even some powerful governments are dismantling the national vaccination order, our Arothera device can serve as a quality alternative. We are no longer looking at the $3,86B market of pleasant smells with the nice bonus of killing viruses in the air, but at the airborne vaccination market, which costs about $88B.  Pfizer and Moderna, hold on, we're coming to you! 😁  

A new surge in COVID cases is on the way. It can damage every system in your body, even if you don't get very sick. Take it serious, be vigilant. Respiratory disease screening is our thing, and we'd love to chat with you about it if you're interested: Sales@RAIsonance.ai or Kirt Monteferrante Paul McLenaghan Kraig Monteferrante #COVID #Respiratory #Health #AI #Innovation #TB #Flu